Atlas Trials

A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous

Clinical trial NCT03265171 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT03265171
Sponsor
Prometic Biotherapeutics, Inc.
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Hypoplasminogenemia

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.